National Pharmacy Association: SAR refusal, NoReply threats, and what our logs show TL;DR The National Pharmacy Association (NPA) refused my Subject Access Request as “manifestly unfounded,” threatened defamation and harassment,…
Posts published in “IPS Pharma”
NPA Misrepresentation Claim, Opening With Gateshead Access Panel NPA Misrepresentation Claim, Opening With Gateshead Access Panel By Kieron JH · 23 September 2025 Editor note: This page is background. It…
NPA On-Net Access, Cloaked Cloud Probes, and Honeypot Hits They Read, They Probed, We Logged Everything By Kieron JH · 23 September 2025 Summary: We captured on-net access from the…
We keep receipts: IPS Pharma’s 2018 privacy notice, NPA’s response, and the misrepresentation claim By Kieron JH · The Reasonable Adjustment Since the start of September we have been taking…
Read, Noted, Ignored: What Our Logs Show Date: 19 September 2025 Read, Noted, Ignored: What Our Logs Show Short version: they read the emails, clicked the links, and still chose…
IPS, from first choice to question marks Published 16 September 2025 IPS, from first choice to question marks For a long time patients talked about IPS as the safest pair…
DEFCON Domains: Why We Bought Them DEFCON Domains: Why We Bought Them By The Reasonable Adjustment – 15 September 2025 What We Did Over the past few months, we’ve quietly…
IPS Pharma: Pattern, Gaslighting, and Consequences By Kieron JH | The Reasonable Adjustment The medical cannabis supply chain only works if patients can trust it. Over recent months, reports from…
NPA: Statement, Context, and Invitation to Comment NPA: Statement, Context, and Invitation to Comment Published by The Reasonable Adjustment • Last updated 10 September 2025 Plain-English summary. We are publishing…
Progress Report: NPA fixed links, Puro moved fast, IPS still stuck on 2018 Progress Report: NPA fixed links, Puro moved fast, IPS still stuck on 2018 Published: 5 September 2025…